Discover three stocks with strong income potential that are worth considering on September 1st:
BlackRock TCP Capital Corp. (TCPC): This company, which specializes in business development, has seen a 5.8% increase in its earnings estimate for the current year over the past 60 days.
BLACKROCK TCP CAPITAL CORP. Price and Consensus
BLACKROCK TCP CAPITAL CORP. price-consensus-chart | BLACKROCK TCP CAPITAL CORP. Quote
This stock, which has a Zacks Rank #1 (Strong Buy), offers a dividend yield of 11%, higher than the industry average of 10.1%.
BLACKROCK TCP CAPITAL CORP. Dividend Yield (TTM)
BLACKROCK TCP CAPITAL CORP. dividend-yield-ttm | BLACKROCK TCP CAPITAL CORP. Quote
Penske Automotive Group, Inc. (PAG): This company, involved in diversified transportation services, has experienced a 5.9% increase in its earnings estimate for the current year over the past 60 days.
Penske Automotive Group, Inc. Price and Consensus
Penske Automotive Group, Inc. price-consensus-chart | Penske Automotive Group, Inc. Quote
This Zacks Rank #1 stock offers a dividend yield of 1.7%, higher than the industry average of 0.7%.
Penske Automotive Group, Inc. Dividend Yield (TTM)
Penske Automotive Group, Inc. dividend-yield-ttm | Penske Automotive Group, Inc. Quote
Coca-Cola FEMSA, S.A.B. de C.V. (KOF): This franchise bottling company has seen a 6.6% increase in its earnings estimate for the current year over the past 60 days.
Coca Cola Femsa S.A.B. de C.V. Price and Consensus
Coca Cola Femsa S.A.B. de C.V. price-consensus-chart | Coca Cola Femsa S.A.B. de C.V. Quote
This Zacks Rank #1 stock offers a dividend yield of 1.6%, higher than the industry average of 0.0%.
Coca Cola Femsa S.A.B. de C.V. Dividend Yield (TTM)
Coca Cola Femsa S.A.B. de C.V. dividend-yield-ttm | Coca Cola Femsa S.A.B. de C.V. Quote
Check out the full list of top-ranked stocks here.
For more top income stocks, explore our premium screens.
Zacks Names “Single Best Pick to Double”
Out of thousands of stocks, five Zacks experts have chosen their favorite stock, each with the potential to skyrocket +100% or more in the coming months. Among them, Director of Research Sheraz Mian has selected one with the most explosive upside.
This company is credited with a “watershed medical breakthrough” and is actively developing a pipeline of projects that could significantly impact patients with liver, lung, and blood-related diseases. It’s an opportune investment emerging from its bear market lows.
This stock has the potential to rival or surpass recent Stocks Set to Double, such as Boston Beer Company (+143.0% in 9 months) and NVIDIA (+175.9% in 1 year).
Free: See Our Top Stock And 4 Runners-Up
Penske Automotive Group, Inc. (PAG): Free Stock Analysis Report
Coca Cola Femsa S.A.B. de C.V. (KOF): Free Stock Analysis Report
BLACKROCK TCP CAPITAL CORP. (TCPC): Free Stock Analysis Report
Read this article on Zacks.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
